Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia

INTRODUCTION: Lomitapide is a microsomal triglyceride transfer protein inhibitor for patients with homozygous familial hypercholesterolaemia. Due to its mechanism of action, potential hepatic effects of lomitapide are of clinical interest. This study aimed to determine the long‐term hepatic safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrey, Dominique, D'Erasmo, Laura, O'Brien, Sallyann, Arca, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Genetics and Rare Liver Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107656/
https://www.ncbi.nlm.nih.gov/pubmed/36520008
http://dx.doi.org/10.1111/liv.15497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107656/
https://www.ncbi.nlm.nih.gov/pubmed/36520008
http://dx.doi.org/10.1111/liv.15497

Ejemplares similares